Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Oliver DörrClaudia WaltherChristoph LiebetrauTill KellerThomas SommerNiklas F BoederMatthias BayerPascal BauerHelge MöllmannLuise GaedeChristian TroidlSandra VossTimm BauerChristian W HammHolger Nef

Published in: Clinical cardiology (2018)

There was an association between low Gal-3 and ST2 plasma levels and successful MR reduction in patients with severe MR undergoing PMVR using the MitraClip system.

Keyphrases

mitral valve
patients undergoing
contrast enhanced
magnetic resonance
minimally invasive
early onset
ultrasound guided
magnetic resonance imaging
radiofrequency ablation
computed tomography